Home >> News >> Business >> Antinuclear Antibody Testing Market Is Expected To Reach US$ 1,588.7 Bn By 2025

Antinuclear Antibody Testing Market Is Expected To Reach US$ 1,588.7 Bn By 2025

According to the latest market report published by Credence Research, Inc. “Antinuclear Antibody Tests Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the global antinuclear antibody tests market was valued at US$ 649 Mn in 2016, and is expected to reach US$ 1,588.7 Mn by 2025, expanding at a CAGR of 9.8% from 2017 to 2025

Browse the full report Antinuclear Antibody Tests Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at https://www.credenceresearch.com/report/anti-nuclear-antibody-testing-ana-market

Market Insights

An antinuclear antibody tests (ANA) are used to evaluate quantity and pattern of antibodies in the blood. It is used to evaluate autoimmune disorders that might affect tissues and organ throughout systemic body. It is commonly used to diagnose rheumatoid arthritis, systemic lupus erythematosus (SLE), Sjögren syndrome, scleroderma and polymyositis. Usually any foreign body such as virus or bacteria if enters the body, would be destroyed by the immune system. In autoimmune disorder, body produces ANA as group of antibodies, as the immune system is not able to differentiate between “self” and “nonself.” It targets the nucleus of the cell and destroys the tissue and the organ. Rising prevalence of autoimmune disorders, advancement in lab automation and use of novel biomarker are the key factors driving the growth of antinuclear antibody tests market

The global antinuclear antibody tests market is segmented by product type into reagent & assays kits, systems and software & services. Reagents and assay kits occupy the largest share of global antinuclear antibody tests market. The global antinuclear antibody tests market is segmented by technique type into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay and multiplex assay. Enzyme-Linked Immunosorbent Assay (ELISA) dominates the global antinuclear antibody tests market. By disease, global antinuclear antibody tests market is segmented into rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma and other diseases. Rheumatoid arthritis currently occupies the largest market share of global antibody tests market due to rising prevalence of rheumatoid arthritis.

As of the current market scenario, North America dominated the global antinuclear antibody tests market followed by the Europe. Factors contributing to the growth of North America market includes increase in prevalence of autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus (SLE), growing introduction and availability of novel diagnostic tools and supportive reimbursement policies. Asia Pacific is the fastest growing regional market for antinuclear antibody tests.

Market Competition Assessment:

Key players in the global antinuclear antibody test market are Alere, Inc., EUROIMMUN AG, ERBA Diagnostics, Inc., Trinity Biotech plc, Bio-Rad Laboratories, Inc., Immuno Concepts, Thermo Fisher Scientific, Inc., Antibodies, Inc., Inova Diagnostics, Zeus Scientific, Inc. and others.

Key Market Movements:

–  Rising awareness about autoimmune disorders and availability of novel diagnostic tools and kits also contribute to the growth of antinuclear antibody tests market

– Prevalence of diagnosed autoimmune conditions is highest in EU-5 with 9%, followed by China and U.S. with 8% and 7% respectively. Autoimmune diseases is one of leading cause of mortality in developed countries. Thus rising prevalence of autoimmune disorder is the pivotal factor driving the growth of antinuclear antibody tests market

Based on the type of products, the global antinuclear antibody tests market is segmented as follows:

  • Reagents & Assay Kits
  • Software & Services
  • Systems

In 2016, reagents and assay kits occupy the largest share of global antinuclear antibody test market. Growth in this segment is observed due to rise in prevalence of autoimmune disease and reagent rental agreements. Clinical laboratories are benefitting from reagent rentals and cost per test contracts in terms of cost containment that would further help them to buy new instruments. In the recent years, multiplex ANA kits have evolved as the most convenient method and led to faster diagnosis outcomes.

Anti-Nuclear Antibody Testing (ANA) Market

Based on the type of techniques, the global antinuclear antibody tests market is segmented as follows:

  • Elisa
  • Immunofluorescence Assay
  • Multiplex Assay

There is increase in trend observed in autoimmune disorders, mainly due to awareness about the disease and improved diagnostic tools. Enzyme-Linked Immunosorbent Assay (ELISA) dominates the global antinuclear antibody test market. Two most common ANA screening tests – indirect immunofluorescence and ELISA are frequently practiced in commercial labs. Though ELISA is most frequently used, there is a paradigm shift observed towards usage of multiplex immunoassays. High adoption of multiplex immunoassays by companies and laboratories drives the fast growth of this segment.

Anti-Nuclear Antibody Testing (ANA) Market

Based on the type of diseases, the global antinuclear antibody tests market is segmented as follows:

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Sjögren’s Syndrome
  • Scleroderma
  • Other Diseases

Lately, the prevalence of autoimmune diseases, particularly in developed countries has increased exponentially. Rapid rise in autoimmune disease prevalence is associated with major environmental factors such as infection, ecology and nutrition. Rheumatoid arthritis occupies the largest revenue share of the global antibody tests market due to rising prevalence of rheumatoid arthritis. According to WHO studies, prevalence of rheumatoid arthritis ranges from 0.3%-1% and commonly observed in women and developed countries. According Lupus Foundation of America study, around 1.5 Mn American suffer from Lupus and at least 5 Mn across the world.

Anti-Nuclear Antibody Testing (ANA) Market

For the purpose of this study, the global antinuclear antibody tests market is geographically categorized into:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Anti-Nuclear Antibody Testing (ANA) Market

In 2016, North America dominated the global antinuclear antibody tests market followed by Europe. Rising incidence of autoimmune diseases, increasing healthcare expenditure, extensive research and development for novel biomarkers, and favorable reimbursement policies, are some of the major factors that fuel the growth of antinuclear antibody tests market in North America. Around 3% population in U.S. are affected by autoimmune disorders. Asia Pacific is anticipated to be the fastest growing market in the forecast period 2017-2025. Increase in incidence of chronic autoimmune diseases such as rheumatoid arthritis, rising awareness about disease and improved diagnostics technology, improving healthcare infrastructure and government funding are contributing to the growth of antinuclear antibody tests market in Asia Pacific…

Sample Request: https://www.credenceresearch.com/sample-request/58594

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Company Name: Credence Research, Inc.

Contact Person: Chris Smith, Global Sales Manager

Email: sales@credenceresearch.com

Phone: +1-800-361-8290

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

City: SAN JOSE

State: California

Country: United States

Web: https://www.credenceresearch.com/

Leave a Reply

Your email address will not be published. Required fields are marked *